ATS 2019 Virtual Final Program

BASIC • TRANSLATIONAL THEMATIC POSTER SESSION C52 USE YOUR ILLUSION II: CLINICAL RESEARCH IN PAH 9:15 a.m. - 4:15 p.m. KBHCCD Area J (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : E.R. Swenson, MD, Seattle, WA P1157 Real-World Evidence from the OPUS Registry: An Insight into Pulmonary Arterial Hypertension Risk Assessment Parameters in Clinical Practice/ K.M. Chin, R.N. Channick, N.H. Kim, M. Brand, A. Morganti, M. Selej, V.V. McLaughlin, Dallas, TX, p.A5079 P1158 Infection-Related Hospitalization in Pulmonary Arterial Hypertension Patients/ Z. Salman, S. Beshay, Z. Safdar, Houston, TX, p.A5080 P1159 Impact of Parenchymal Lung Disease in Echocardiographic Estimate of Pulmonary Artery Pressure in Sarcoidosis Patients/ M. Huitema, M. Post, J.C. Grutters, V. Kouranos, O.A. Shlobin, S.D. Nathan, A.U. Wells, D.A. Culver, J. Barney, R. Gupta, E.M. Carmona Porquera, E.H. Alhamad, M.B. Scholand, M. Wijsenbeek, S. Ganesh, E.E. Lower, R.P. Baughman, P. Engel, Nieuwegein, Nether, p.A5081 P1160 Evaluation of Quality of Life in a Cohort of Patients Diagnosed with Pulmonary Arterial Hypertension in Bogotá, Using the Colombian Version of the CAMPHOR Questionnaire/ C. Villaquiran-Torres, M. Ocampo, S. Villazon, S. Moreno-Luna, R. Duenas-Villamil, J. Lutz-Pena, P. Acuna, Bogotá, Colombia, p.A5082 P1161 Pulmonary Hypertension and Obstructive Sleep Apnea (OSA): A Retrospective Review in a Community Based Setting/ M. Reichmuth, A. Patel, K. Shapiro, J. Gordon, Pueblo, CO, p.A5083 Facilitator : A. Sweatt, MD, Stanford, CA P1162 Pulmonary Hypertension in Chronic Kidney Disease After Renal Transplant: Risk Factor or Consequence/ D.J. De La Zerda, R.A. Alvarez, J. Villamizar, Miami, FL, p.A5084 P1163 Subcutaneous Adipose Tissue Is Associated with Presence of Pulmonary Hypertension in Advanced Lung Disease/ H. Pan, M.R. Anderson, J.M. Diamond, S.M. Palmer, M. Oyster, D. Torigian, M. Porteous, S.M. Arcasoy, Y. Tong, J. Udupa, J.D. Christie, S.M. Kawut, D.J. Lederer, N. Al-Naamani, Philadelphia, PA, p.A5085 P1164 Prognostic Factors and Hospital Mortality in Patients with Acute Decompensated Pulmonary Arterial Hypertension Admitted to ICU/ M. Garcia, B.R. Macedo, R. Souza, P. Caruso, Sao Paulo, Brazil, p.A5086 P1165 Association of Baseline Pulmonary Vascular Resistance with Mortality in a Database of Patients with Idiopathic Pulmonary Arterial Hypertension/ M. Lucki, N. Al-Naamani, D. Pinder, K. Boyle, A. McCormick, M. Patel, C. Burwell, C.L. Archer-Chicko, A. Smith, J.A. Mazurek, H.I. Palevsky, J.S. Fritz, S. Pugliese, S.M. Kawut, Philadelphia, PA, p.A5087 P1166 When Pulmonary Hypertension Is Due to Sequelae of Pulmonary Tuberculosis/ C.F. Koudessi, M. Fafa Cissé, S. Koné, N.M.J. Ouethy, Dakar, Senegal, p.A5088 Facilitator : K. Goss, MD, Madison, WI P1167 Genomic Test Results May Improve REVEAL Risk Calculation Results from the United States Pulmonary Hypertension Scientific Registry (USPHSR)/ C.G. Elliott, R. Benza, H.W. Farber, E.D. Austin, D.B. Badesch, J. Badlam, W.K. Chung, A.E. Frost, Y. Chang, A. Poms, K. Feldkircher, K. Lutz, M. Pauciulo, W.C. Nichols, Murray, UT, p.A5089 P1168 Self-Reported Pulmonary Hypertension (PH) Referral Trends Amongst U.S.-Based Physicians/ M.P. Gray, D.B. Badesch, T.M. Bull, H.M. DuBrock, V. De Jesus Perez, T. Lahm, P.J. Leary, A. Laughlin, R. Aune, L.M. Brown, Silver Spring, MD, p.A5090 P1169 Awareness and Diagnostic Trends of Pulmonary Hypertension (PH) Amongst U.S.-Based Physicians/ M.P. Gray, D.B. Badesch, T.M. Bull, H.M. DuBrock, V. De Jesus Perez, T. Lahm, P.J. Leary, A. Laughlin, R. Aune, L.M. Brown, Silver Spring, MD, p.A5091 P1170 A Description of the Pulmonary Vascular Changes in Combined Pulmonary Fibrosis and Emphysema from Explanted Lung Pathology Specimens/ N. Tobey, A. Banga, Y. Butt, T.G. Shah, Dallas, TX, p.A5092 P1171 Pulmonary Vascular Histopathology in Explanted End-Stage Parenchymal Lung Disease/ Y. Dotan, J.I. Stewart, A. Gangemi, H. Wang, A. Aneja, B. Chakraborty, C. Dass, N. Marchetti, G.J. Criner, A.J. Mamary, Bethlehem, PA, p.A5093 Facilitator : B.B. Graham, MD, Aurora, CO P1172 Additive Effect of Sleep Disordered Breathing on the Severity of Pulmonary Vascular Disease in Patients with Pulmonary Arterial Hypertension/ R. Puri, R. Vanderpool, S. Airhart, H. Erickson, L. Hansen, A. Lizarraga, A.A. Desai, J.G.N. Garcia, J.X.J. Yuan, F.P. Rischard, Tucson, AZ, p.A5094 P1173 Characterizing the Accessibility and Burdens of Medications in the Treatment of Pulmonary Arterial Hypertension/ S. Huang, D.R. Fraidenburg, R.H. Anguiano, Chicago, IL, p.A5095 P1174 Sleep Disordered Breathing Phenotype Across Pulmonary Hypertension Group: Insights from the Pulmonary Vascular Disease Phenomics Study/ R. Mehra, L. Wang, R. Nawabit, S. Kaur, K.B. Highland, N.S. Hill, Cleveland, OH, p.A5096 P1175 Estrogen Metabolism in Portopulmonary Hypertension (POPH): A Case-Control Study/ N. Al-Naamani, M.J. Krowka, K. Forde, G.A. Heresi, T.M. Bull, K.E. Roberts, S. Bartolome, A. Hemnes, K. Krok, G. Lin, J.K. Oh, C.D. Mottram, P.D. Scanlon, M. Patel, H.M. DuBrock, E.D. Austin, M. Fallon, S.M. Kawut, Philadelphia, PA, p.A5097 ATS 2019 • Dallas, TX TUESDAY • MAY 21 265 TUESDAY MORNING